End-of-day quote
Colombo S.E.
06:00:00 2024-05-02 pm EDT
|
5-day change
|
1st Jan Change
|
61.2
LKR
|
-0.65%
|
|
+0.99%
|
+20.00%
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
5,668
|
11,890
|
16,421
|
22,139
|
30,109
|
-
|
Enterprise Value (EV)
1 |
5,668
|
11,890
|
16,421
|
22,139
|
30,109
|
30,109
|
P/E ratio
|
4.94
x
|
7.82
x
|
6.04
x
|
9.64
x
|
-
|
-
|
Yield
|
-
|
6.6%
|
-
|
-
|
3.27%
|
5.07%
|
Capitalization / Revenue
|
0.27
x
|
0.49
x
|
-
|
-
|
0.54
x
|
0.48
x
|
EV / Revenue
|
0.27
x
|
0.49
x
|
-
|
-
|
0.54
x
|
0.48
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.13
x
|
-
|
-
|
1.69
x
|
1.35
x
|
Nbr of stocks (in thousands)
|
448,662
|
448,662
|
448,662
|
491,974
|
491,974
|
-
|
Reference price
2 |
12.63
|
26.50
|
36.60
|
45.00
|
61.20
|
61.20
|
Announcement Date
|
5/27/20
|
5/31/21
|
5/30/22
|
5/25/23
|
-
|
-
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
20,831
|
24,339
|
-
|
-
|
55,979
|
62,230
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
3,669
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
15.07%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
3,309
|
-
|
-
|
-
|
-
|
Net income
|
-
|
1,520
|
2,721
|
2,264
|
-
|
-
|
Net margin
|
-
|
6.25%
|
-
|
-
|
-
|
-
|
EPS
|
2.557
|
3.390
|
6.060
|
4.670
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
1.750
|
-
|
-
|
2.000
|
3.100
|
Announcement Date
|
5/27/20
|
5/31/21
|
5/30/22
|
5/25/23
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
17.2%
|
-
|
-
|
25.2%
|
25.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
-
|
23.50
|
-
|
-
|
36.30
|
45.50
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/27/20
|
5/31/21
|
5/30/22
|
5/25/23
|
-
|
-
|
Last Close Price
61.2
LKR Average target price
81.15
LKR Spread / Average Target +32.60% Consensus |
1st Jan change
|
Capi.
|
---|
| +20.00% | 101M | | -31.79% | 15.36B | | -21.99% | 12.45B | | -22.64% | 6.75B | | +9.74% | 6.14B | | -10.91% | 6.07B | | +0.58% | 4.78B | | +59.24% | 4.53B | | -9.00% | 3.81B | | -12.53% | 3.43B |
Other Drug Retailers
|